Institut Pasteur de Tunis
Records under this name other than the patents Institut Pasteur de Tunis holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 5 of 5 · Back to Institut Pasteur de Tunis
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,888,492 | Polypeptides of Leishmania Major and Polynucleotides Encoding Same and Vaccinal, Therapeutical and Diagnostic Applications Thereof held by Institut Pasteur and Institut Pasteur de Tunis Lapsed on the fee record Ended Feb 15, 2019 · High confidence | Lapsed on the fee record | Ended Feb 15, 2019 | High confidence |
| US 7,700,121 | Gene Associated with Leishmania Parasite Virulence held by Institut Pasteur de Tunis and Institut Pasteur Lapsed on the fee record Ended Apr 20, 2018 · High confidence | Lapsed on the fee record | Ended Apr 20, 2018 | High confidence |
| US 8,551,500 | Composition Comprising the N-Terminal Region of Histone H2B of Leishmania - Use Thereof for Inducing an Immune Response held by Institut Pasteur and Institut Pasteur de Tunis Lapsed on the fee record Ended Oct 8, 2017 · Medium confidence | Lapsed on the fee record | Ended Oct 8, 2017 | Medium confidence |
| 12/100,984 | Method for the Production of High-Level Soluble Human Recombinant Interferon Alpha in E. Coli and Vectors Useful for Such a Production held by Instittut Pasteur and Institut Pasteur de Tunis Abandoned Abandoned Aug 28, 2011 | Abandoned | Abandoned Aug 28, 2011 | |
| 12/996,210 | RECOMBINANT POLYPEPTIDES OF LEISHMANIA INFANTUM (LeIF POLYPEPTIDES) held by Institut Pasteur and Institut Pasteur de Tunis Abandoned Abandoned Aug 5, 2015 | Abandoned | Abandoned Aug 5, 2015 |